SARS-CoV-2大流行期间以患者为中心的居家癌症筛查态度
研究通过门诊电子病历识别三组健康负担不同的成人(COVID住院幸存者、非COVID呼吸道疾病阳性者、2型糖尿病者),132人完成在线调查评估对居家结直肠癌和宫颈癌筛查的接受度。女性对尿液和阴道primary HPV检测的接受度分别为64%和59%,男女对FIT或Cologuard居家结直肠癌筛查接受度为60%。调整教育后,对居家尿液/阴道筛查持积极态度的女性对结直肠癌筛查持积极态度的aOR分别为48.7和23.2。
要点
- 居家结直肠癌筛查(FIT或Cologuard)在男女中接受度为60%。
- 女性对尿液和阴道primary HPV检测接受度分别为64%和59%。
- 对居家HPV筛查持积极态度与对结直肠癌筛查积极态度强烈相关。
核心结论
- 居家结直肠癌筛查和primary HPV检测在男女中均可接受,未来可能提高筛查依从性。
研究设计与样本
- 通过门诊电子病历识别三组健康负担不同的成人,132名受访者(58%女性)完成在线调查,回答关于居家结直肠癌或宫颈癌筛查接受度的假设病例。
主要发现
- 女性对尿液和阴道primary HPV检测的接受度分别为64%和59%。
- 男女对FIT或Cologuard居家结直肠癌筛查的接受度为60%。
- 调整教育后,对居家尿液筛查持积极态度的女性对结直肠癌筛查持积极态度的aOR=48.7(95% CI: 7.1, 337)。
- 调整教育后,对居家阴道筛查持积极态度的女性对结直肠癌筛查持积极态度的aOR=23.2(95% CI: 3.8, 142)。
临床怎么用
- 全科医生可考虑向患者提供居家结直肠癌筛查(FIT或Cologuard)和primary HPV检测选项以提高筛查接受度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
COVID-19 has caused disruptions in health care, in particular cancer screenings. The primary aim of our work was to evaluate the degree to which populations were accepting of home-based screenings for colorectal cancer (CRC) and cervical cancer (primary HPV testing). Three groups of adults having distinct health burdens which may affect acceptance of home-based cancer screening were identified through outpatient electronic medical records as follows as either having survived a COVID hospitalization, having been positive for non-COVID respiratory illness or having type 2 diabetes. 132 respondents (58% female) completed an online survey with hypothetical cases about their acceptance of home-based CRC or cervical cancer screening. Among females, urine and vaginal screening for primary HPV testing was acceptable to 64% and 59%, respectively. Among both males and females, CRC home screening with fecal immunochemical test (FIT) or Cologuard was acceptable to 60% of the respondents. When adjusting for education, women with a positive attitude toward home-based urine /vaginal screening were 49 times and 23 times more likely to have a positive attitude toward CRC screening (aOR=48.7 (95% CI: 7.1, 337) and aOR=23.2 (95% CI: 3.8, 142), respectively). This report indicates that home-based cancer screens for CRC and primary HPV testing are acceptable to men and women and may allow for greater compliance with screening in the future.
引用
- El Khoury C, Crespo Albiac L, O'Dwyer MC, et al. Patient-centered home cancer screening attitudes during SARS-CoV-2 pandemic. Ann Fam Med. 2022. PMID: 36857034. doi:10.1370/afm.20.s1.2639
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。